158 related articles for article (PubMed ID: 22160650)
1. High dose rate brachytherapy using molds after chemoradiotherapy for oral cavity cancer.
Chatani M; Tsuboi K; Yagi M; Fujiwara K; Tachimoto R; Yoshioka H
Jpn J Radiol; 2012 Jan; 30(1):40-4. PubMed ID: 22160650
[TBL] [Abstract][Full Text] [Related]
2. Customized mold brachytherapy for oral carcinomas through use of high-dose-rate remote afterloading apparatus.
Ariji E; Hayashi N; Kimura Y; Uchida T; Hayashi K; Nakamura T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Apr; 87(4):508-12. PubMed ID: 10225636
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
Unetsubo T; Matsuzaki H; Takemoto M; Katsui K; Hara M; Katayama N; Waki T; Kanazawa S; Asaumi J
Radiat Oncol; 2015 Apr; 10():81. PubMed ID: 25888772
[TBL] [Abstract][Full Text] [Related]
4. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
5. High dose rate versus low dose rate interstitial radiotherapy for carcinoma of the floor of mouth.
Inoue T; Inoue T; Yamazaki H; Koizumi M; Kagawa K; Yoshida K; Shiomi H; Imai A; Shimizutani K; Tanaka E; Nose T; Teshima T; Furukawa S; Fuchihata H
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):53-8. PubMed ID: 9588917
[TBL] [Abstract][Full Text] [Related]
6. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.
Grabenbauer GG; Rödel C; Brunner T; Schulze-Mosgau S; Strnad V; Müller RG; Iro H; Sauer R
Strahlenther Onkol; 2001 Jul; 177(7):338-44. PubMed ID: 11505619
[TBL] [Abstract][Full Text] [Related]
7. Iodine-125 brachytherapy in the management of squamous cell carcinoma of the oral cavity and oropharynx.
Stannard C; Maree G; Tovey S; Hunter A; Wetter J
Brachytherapy; 2014; 13(4):405-12. PubMed ID: 24818781
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer.
Nag S; Schuller D; Pak V; Young D; Grecula J; Bauer C; Samsami N
Radiother Oncol; 1996 Nov; 41(2):125-30. PubMed ID: 9004354
[TBL] [Abstract][Full Text] [Related]
9. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.
Lapeyre M; Hoffstetter S; Peiffert D; Guérif S; Maire F; Dolivet G; Toussaint B; Mundt A; Chassagne JF; Simon C; Bey P
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):37-42. PubMed ID: 10924969
[TBL] [Abstract][Full Text] [Related]
10. Two-piece customized mold technique for high-dose-rate brachytherapy on cancers of the buccal mucosa and lip.
Matsuzaki H; Takemoto M; Hara M; Unetsubo T; Yanagi Y; Katsui K; Katayama N; Yoshio K; Takenobu T; Kuroda M; Kanazawa S; Asaumi J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jan; 113(1):118-25. PubMed ID: 22677692
[TBL] [Abstract][Full Text] [Related]
11. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
Chang LF; Horvath J; Peyton W; Ling SS
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
[TBL] [Abstract][Full Text] [Related]
12. Treatment duration as a prognostic factor for local control and survival in epidermoid carcinomas of the tonsillar region treated by combined external beam irradiation and brachytherapy.
Hoffstetter S; Marchal C; Peiffert D; Luporsi E; Lapeyre M; Pernot M; Bey P
Radiother Oncol; 1997 Nov; 45(2):141-8. PubMed ID: 9424004
[TBL] [Abstract][Full Text] [Related]
13. Treatment of upper gum carcinoma with high-dose-rate customized-mold brachytherapy.
Garrán C; Montesdeoca N; Martínez-Monge R
Brachytherapy; 2008; 7(3):267-9. PubMed ID: 18635026
[TBL] [Abstract][Full Text] [Related]
14. Locally advanced verrucous carcinoma of the oral cavity: treatment using customized mold HDR brachytherapy instead of hemi-maxillectomy.
van Gestel KM; Buurman DJ; Pijls R; Kessler PA; van den Ende PL; Hoffmann AL; Troost EG
Strahlenther Onkol; 2013 Oct; 189(10):894-8. PubMed ID: 23963206
[TBL] [Abstract][Full Text] [Related]
15. Shielding effect of a customized intraoral mold including lead material in high-dose-rate 192-Ir brachytherapy for oral cavity cancer.
Kudoh T; Ikushima H; Honda E
J Radiat Res; 2012; 53(1):130-7. PubMed ID: 22223463
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative radiotherapy in endometrial carcinoma. A retrospective analysis of 541 cases].
Hänsgen G; Nagel M; Dunst J; Enke H
Strahlenther Onkol; 1999 Nov; 175(11):548-53. PubMed ID: 10584124
[TBL] [Abstract][Full Text] [Related]
17. [Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery].
Friedrich RE; Krüll A; Schwarz R; Thurmann H; Plambeck K; Schmelzle R
Strahlenther Onkol; 1997 Oct; 173(10):507-12. PubMed ID: 9381359
[TBL] [Abstract][Full Text] [Related]
18. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal.
Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240
[TBL] [Abstract][Full Text] [Related]
19. Treatment of squamous cell carcinomas of the floor of the mouth and tongue by interstitial high-dose-rate irradiation using iridium-192.
Klein M; Menneking H; Langford A; Koch K; Stahl H
Int J Oral Maxillofac Surg; 1998 Feb; 27(1):45-8. PubMed ID: 9506299
[TBL] [Abstract][Full Text] [Related]
20. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
